Daré Bioscience, Inc. (DARE)

Daré Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	31	30	70	153	51	14
Market Cap Growth	-44.99%	-56.74%	-54.04%	200.95%	272.11%	68.57%
Enterprise Value	28	20	36	102	47	10
PE Ratio	-	-1.01	-2.27	-3.96	-1.86	-0.91
PS Ratio	10.86	10.85	7.04	-	-	-
PB Ratio	-4.48	-6.03	6.34	3.95	-44.20	31.03
P/FCF Ratio	-1.63	-0.77	-3.88	-5.32	-2.02	-1.03
P/OCF Ratio	-1.67	-0.78	-3.89	-5.33	-2.02	-1.03
EV/Sales Ratio	9.88	7.20	3.62	-	-	-
EV/EBITDA Ratio	-1.62	-0.67	-1.17	-2.63	-1.71	-0.68
EV/EBIT Ratio	-1.61	-0.67	-1.17	-2.63	-1.72	-0.68
EV/FCF Ratio	-1.54	-0.51	-2.00	-3.54	-1.86	-0.73
Debt / Equity Ratio	-0.15	-0.28	0.04	0.01	-0.66	1.82
Debt / EBITDA Ratio	-0.06	-0.05	-0.02	-0.01	-0.03	-0.06
Debt / FCF Ratio	-0.05	-0.04	-0.03	-0.01	-0.03	-0.06
Quick Ratio	0.33	0.61	1.15	3.29	0.67	0.95
Current Ratio	0.56	0.86	1.36	3.45	0.91	1.15
Asset Turnover	0.14	0.11	0.21	0	0	0
Return on Equity (ROE)	548.50%	2373.00%	-122.10%	-189.60%	-11098.30%	-541.80%
Return on Assets (ROA)	-139.90%	-120.80%	-63.60%	-119.10%	-322.50%	-255.10%
Return on Capital (ROIC)	305.42%	849.26%	-270.54%	-100.11%	6939.18%	-1155.65%
Earnings Yield	-94.42%	-99.03%	-43.96%	-25.26%	-53.84%	-110.04%
FCF Yield	-98.72%	-129.65%	-25.78%	-18.78%	-49.61%	-97.33%
Buyback Yield / Dilution	-17.54%	-3.23%	-38.29%	-103.23%	-93.15%	-45.16%
Total Shareholder Return	-17.54%	-3.23%	-38.29%	-103.23%	-93.15%	-45.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).